Cardiogen

Cardiogen is described as a peptide and bio-regulator that supports cell function—particularly fibroblasts, which are essential for healing and scar formation. It’s primarily discussed in research contexts related to heart health, with additional notes on tissue healing and signaling effects in other systems.

Caution & Contraindications:
Caution: Use caution in individuals with existing heart conditions or arrhythmias, as it may affect heart rate.
Contraindications: Individuals with severe heart failure.

Reconstitution Options (Vial Format):
• 20 mg

Reconstitution (General Handling):
• Use sterile technique and sanitize the vial stopper before access.
• Add bacteriostatic water slowly along the vial wall to minimize foaming.
• Gently swirl/roll until fully dissolved (avoid vigorous shaking).
• Choose a diluent volume that makes a 1–5 mg dose easy to measure accurately.
• Store according to the product label/spec sheet and protect from light as applicable.

Molecular Formula: C18H31N7O9

Molecular Weight: 489.5 g/mol

PubChem CID: 11583989

Alternative Names: SCHEMBL3194515

In cardiac tissue, Cardiogen appears to promote cardiomyocyte proliferation while tempering fibroblast overactivity. This balance can limit scar formation, improve long-term cardiac remodeling, and reduce apoptosis via p53 down-regulation—key factors in chronic heart failure outcomes.

Interestingly, while p53 suppression aids cardiomyocyte survival, preclinical models of M-1 sarcoma suggest Cardiogen can trigger the opposite effect in tumors—enhancing apoptosis and disrupting aberrant vasculature. Dose-dependent responses highlight its potential role as an adjunctive cancer therapy.

Prostate fibroblasts help orchestrate tumor microenvironments. Studies show Cardiogen can normalize age-related shifts in paracrine signaling, potentially lowering the risk of tumor initiation or slowing progression by restoring a healthier stromal milieu.

Though comparatively early in its research journey, Cardiogen showcases wide-ranging bioregulatory potential—from cardiovascular support to oncologic applications. Its favorable bioavailability in mice and low reported side-effect profile make it a compelling candidate for further study in heart failure, hypertension, and oncology adjuncts.

As with many research peptides, animal dose data do not directly scale to humans. Cardiogen is available strictly for educational and scientific purposes and should be handled by licensed researchers.

PubMed

Article Author :

The above literature was researched, edited and organized by Dr. Logan, M.D. Dr. Logan holds a doctorate degree from https://case.edu/medicine/Case Western Reserve University School of Medicine and a B.S. in molecular biology.

Case Western Reserve University School of Medicine

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The product information featured on this website pertains exclusively to in-vitro studies. In-vitro studies, also known as ‘in glass’ studies, are conducted outside of living organisms. It’s important to emphasize that these products do not constitute medicines or drugs and have not received FDA approval for the prevention, treatment, or cure of any medical conditions, ailments, or diseases. It is crucial to note that the introduction of these products into the bodies of humans or animals is strictly prohibited by law.